Ocalcitinib

16 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1250.0%

Death Rate

Active Ingredients

Ocalcitinib

Administration Routes

Oral

Species Affected

Dog 16

Most Affected Breeds

Terrier - Yorkshire 2

Retriever - Labrador 1

Pug 1

Terrier - West Highland White 1

Bulldog - French 1

Bichon Frise 1

Shih Tzu 1

Spaniel (unspecified) 1

Shepherd Dog - German 1

Beagle 1

Most Reported Reactions

Diarrhoea 4

Elevated alanine aminotransferase (ALT) 4

Vomiting 3

Lethargy (see also Central nervous system depression in 'Neurological') 3

Elevated serum alkaline phosphatase (SAP) 3

Underdose 3

Anorexia 2

Elevated blood urea nitrogen (BUN) 2

Elevated creatinine 2

Decreased urine concentration 2

Weight loss 2

Proteinuria 2

Outcome Breakdown

Outcome Unknown

9 (56.3%)

Recovered/Normal

4 (25.0%)

Ongoing

1 (6.3%)

Died

1 (6.3%)

Euthanized

1 (6.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.